论文部分内容阅读
实验动物在我省医药生产企业 (药厂 )中作为原材料和药品质检手段以及用于新药研究 ,有着重要作用 ,加强药厂实验动物管理将促进我省医药工业发展。通过分析我省药厂实验动物科技的现状 ,指出了现有自愿申报的管理模式不足之处。这种模式使得对药厂实验动物的管理至今仍未全面铺开 ,要完成在药厂普及使用清洁级实验动物的任务更加困难 ,不利于药厂实验动物科技发展。现有管理模式还与产品质量管理的有关法规出现了不协调。通过论证得知应对药厂实验动物工作的管理方法进行改进 ,应改自愿申报的管理模式为强制管理
Laboratory animals in our province pharmaceutical manufacturing enterprises (pharmaceutical) as a means of quality control of raw materials and medicines as well as for the study of new drugs, has an important role in strengthening the experimental animal management of pharmaceutical plants will promote the development of the province’s pharmaceutical industry. By analyzing the status quo of laboratory animal science and technology in our province pharmaceutical factory, pointed out the inadequacy of the existing management model of voluntary declaration. This model makes the management of experimental animals in pharmaceutical companies has not yet fully rolled out to complete the task of popularizing the use of clean-grade laboratory animals in pharmaceutical companies more difficult, is not conducive to the pharmaceutical laboratory animal science and technology development. The existing management model is also inconsistent with the relevant laws and regulations on product quality management. Through the argument that the management of pharmaceutical laboratory animals should be improved management methods should be changed voluntary reporting management model for mandatory management